Agency Forms Undergoing Paperwork Reduction Act Review, 9620-9621 [2022-03708]
Download as PDF
<![CDATA[
9620
Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices
Amount of Award: The approximate
year 1 funding amount will be
$3,000,000 in Federal Fiscal Year (FYY)
2022 funds, subject to the availability of
funds. Funding amounts for years 2–5
will be set at continuation.
Authority: Public Law 108–25 (the
United States Leadership Against HIV
AIDS, Tuberculosis and Malaria Act of
2003).
Period of Performance: September 30,
2022 through September 29, 2027.
Dated: February 15, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–03631 Filed 2–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–21HD]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled the ‘‘One Health
Surveillance for Zoonotic SARS–CoV–2
Events’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on August
13, 2021 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
VerDate Sep<11>2014
19:42 Feb 18, 2022
Jkt 256001
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
One Health Surveillance for Zoonotic
SARS–CoV–2 Events—New—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
NCEZID seeks OMB approval for One
Health Surveillance for Zoonotic SARS–
CoV–2 Events through the use of two
forms: One Health Case Investigation
Form for Animals with SARS–CoV–2,
and Zoonotic SARS–CoV–2 Event Form.
Description of these forms and activities
associated with this study, including
burden to respondents can be found
below.
Zoonotic SARS–CoV–2 Event Form:
Although it is now well established that
SARS–CoV–2 is a zoonotic virus (i.e.,
can be spread between people and
animals), little information exists on the
prevalence or likelihood of zoonotic
transmission events. Currently,
reporting of zoonotic SARS–CoV–2
transmission events is not
systematically reported. Without this
crucial information, however,
interpreting data on SARS–CoV–2
infection in animals, especially the
overall contribution of zoonotic
transmission to the spread of COVID–
19, is incomplete. The information
gathered using this surveillance
mechanism will provide insight into the
role of animals in SARS–CoV–2
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
transmission and will also provide
context for understanding prevalence of
linked human and animal infections
throughout the nation.
Positive SARS–CoV–2 animal samples
must be confirmed by United States
Department of Agriculture (USDA)
National Veterinary Services Lab
(NVSL); however, without the proposed
surveillance mechanism, data on linked
human and animal transmission events
which yield negative results would not
be tracked at the national level. CDC
and USDA guidance recommends statelevel health authorities, namely state
public health veterinarians and state
animal health officials, are involved in
approving and coordinating animal
SARS–CoV–2 testing. These officials are
therefore the primary target audience for
this surveillance form, in addition to
tribal, local and territorial health
authorities. The Zoonotic SARS–CoV–2
Event form includes questions intended
to improve our understanding of the
number of cases state officials are asked
to consult upon regarding SARS–CoV–
2 testing for potential zoonotic
transmission events, the proportion of
those events that are tested for SARS–
CoV–2, and corresponding relevant
epidemiological data (epidemiological
links to other cases of SARS–CoV–2 in
people or animals, clinical signs, etc.),
results, etc. This form will fill a needed
gap over the next three years.
In addition to the primary reason for
the Zooonotic SARS–CoV–2 Event form,
it will also be used to replace paperbased reporting for CDC-funded
research. Currently, CDC’s One Health
Office has funded surveillance and
research at sites throughout the nation.
This surveillance form will be used to
report all linked human and animal
testing for SARS–CoV–2 to CDC that is
occurring through funded surveillance
activities, including the status and
circumstances for testing. This will
relieve the requirement for less secure
reporting such as paper-based reporting
forms sent through email.
More broadly, we expect this form
may be generalized in the future to
encapsulate surveillance for other
zoonotic respiratory viruses. This
surveillance form therefore offers the
opportunity to test and iterate upon
surveillance mechanisms prior to the
advancement of a broader surveillance
system.
One Health Case Investigation Form
for Animals with SARS–CoV–2:
Currently, most animal samples that test
positive for SARS–CoV–2 are confirmed
by USDA NVSL, and are reported to the
World Organization for Animal Health
(OIE). However, the information
collected is largely restricted to
E:\FR\FM\22FEN1.SGM
22FEN1
9621
Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices
information on the animal case,
including animal species, number of
affected animals, and clinical signs.
Richer epidemiological data, including
the routes that animals become exposed
to SARS–CoV–2 and potential
transmission events back to people, are
needed to better understand the
zoonotic potential of SARS–CoV–2,
whether transmission is becoming
sustained among animal populations,
and the public health risks that infected
animals may pose. Through this data
collection tool, state and local public
health and animal health officials will
be able to use a standardized approach
to collect epidemiological data while
conducting One Health epidemiologic
investigations over the tool’s expected
reporting lifespan of three years.
CDC and USDA guidance
recommends state-level health
authorities, namely state public health
veterinarians and state animal health
officials, conduct follow-up
investigations if and when an animal is
identified as positive for SARS–CoV–2.
These officials, in addition to other
state, tribal, local, and territorial (STLT)
collaborators conducting research or
surveillance within their jurisdiction are
therefore an appropriate target audience
for this surveillance form. This form
involves voluntary reporting from STLT
health officials conducting
epidemiological investigations to enter
case information and return it to CDC.
This tool was designed by CDC staff at
the request of STLT partners.
These data will be used to describe
the transmission dynamics and natural
history of SARS–CoV–2 infection.
Specifically, this tool will assist in
collecting and compiling data to better
understand the zoonotic potential of
SARS–CoV–2 from humans or other
sources, and the role animals infected
with SARS–CoV–2 may play in onward
transmission to humans or other
animals.
CDC requests approval for an
estimated 9,000 annual burden hours for
this collection. There are no costs to
respondents other than their time to
participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State, tribal, local, and territorial health officials.
State, tribal, local, and territorial health officials.
One Health Case Investigation Form for Animals with SARS–CoV–2.
One Health Consultation Form ......................
Jeffrey M. Zirger,
Lead,Information Collection Review
Office,Office of Scientific Integrity,Office of
Science,Centers for Disease Control and
Prevention.
program planning in the Eastern Cape
Province of South Africa. Funding
amounts for years 2–5 will be set at
continuation.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
Eastern Cape Department of Health,
South Africa
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $1,250,000 for
Year 1 of funding to the Eastern Cape
Department of Health, South Africa. The
award will strengthen public health
policy implementation, strengthen
Human Resources for Health (HRH)
management, improve supply chain
management, and strengthen Strategic
Information (SI) management for
SUMMARY:
VerDate Sep<11>2014
19:42 Feb 18, 2022
Jkt 256001
The period for this award will be
September 30, 2022 through September
29, 2027.
FOR FURTHER INFORMATION CONTACT:
Rayna Taback-Esra, Center for Global
Health, Centers for Disease Control and
Prevention, P.O. Box 9536, Pretoria,
0001, South Africa, Telephone: 800–
232–6348, Email: wxk7@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will fund the
Eastern Cape Department of Health to
strengthen public health policy
implementation, strengthen HRH
management, improve supply chain
management, and strengthen strategic
information management for program
planning. Strengthened health systems
will support the faster adoption of
implementation of key policies and lead
to a more efficient HIV/TB program in
the Eastern Cape Province of South
Africa. The East Cape Department of
Health South Africa is in a unique
position to conduct this work as it is
responsible for the management of the
provincial health budget and delivery of
all provincial health services.
DATES:
[FR Doc. 2022–03708 Filed 2–18–22; 8:45 am]
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
20
1
80
400
15/60
Purpose of the Award: The purpose of
this award is to support a more efficient
HIV/TB program in the Eastern Cape
Province through improved HRH
management, enhanced supply chain
management, and strengthened SI
management.
Amount of Award: The approximate
year 1 funding amount will be
$1,250,000 in Federal Fiscal Year (FFY)
2022 funds, subject to the availability of
funds. Funding amounts for years 2–5
will be set at continuation.
Authority: The program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2022 through September 29, 2027.
Dated: February 15, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–03720 Filed 2–18–22; 8:45 am]
BILLING CODE 4163–18–P
Recipient: Eastern Cape Department of
Health, South Africa.
Frm 00059
Fmt 4703
Sfmt 9990
Average burden per response
(hours)
50
Summary of the Award
PO 00000
Number of
responses per
respondent
E:\FR\FM\22FEN1.SGM
22FEN1
]]>Agencies
[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
[Notices]
[Pages 9620-9621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03708]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-21HD]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled the ``One Health Surveillance for Zoonotic
SARS-CoV-2 Events'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
August 13, 2021 to obtain comments from the public and affected
agencies. CDC received one comment related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
One Health Surveillance for Zoonotic SARS-CoV-2 Events--New--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
NCEZID seeks OMB approval for One Health Surveillance for Zoonotic
SARS-CoV-2 Events through the use of two forms: One Health Case
Investigation Form for Animals with SARS-CoV-2, and Zoonotic SARS-CoV-2
Event Form. Description of these forms and activities associated with
this study, including burden to respondents can be found below.
Zoonotic SARS-CoV-2 Event Form: Although it is now well established
that SARS-CoV-2 is a zoonotic virus (i.e., can be spread between people
and animals), little information exists on the prevalence or likelihood
of zoonotic transmission events. Currently, reporting of zoonotic SARS-
CoV-2 transmission events is not systematically reported. Without this
crucial information, however, interpreting data on SARS-CoV-2 infection
in animals, especially the overall contribution of zoonotic
transmission to the spread of COVID-19, is incomplete. The information
gathered using this surveillance mechanism will provide insight into
the role of animals in SARS-CoV-2 transmission and will also provide
context for understanding prevalence of linked human and animal
infections throughout the nation.
Positive SARS-CoV-2 animal samples must be confirmed by United
States Department of Agriculture (USDA) National Veterinary Services
Lab (NVSL); however, without the proposed surveillance mechanism, data
on linked human and animal transmission events which yield negative
results would not be tracked at the national level. CDC and USDA
guidance recommends state-level health authorities, namely state public
health veterinarians and state animal health officials, are involved in
approving and coordinating animal SARS-CoV-2 testing. These officials
are therefore the primary target audience for this surveillance form,
in addition to tribal, local and territorial health authorities. The
Zoonotic SARS-CoV-2 Event form includes questions intended to improve
our understanding of the number of cases state officials are asked to
consult upon regarding SARS-CoV-2 testing for potential zoonotic
transmission events, the proportion of those events that are tested for
SARS-CoV-2, and corresponding relevant epidemiological data
(epidemiological links to other cases of SARS-CoV-2 in people or
animals, clinical signs, etc.), results, etc. This form will fill a
needed gap over the next three years.
In addition to the primary reason for the Zooonotic SARS-CoV-2
Event form, it will also be used to replace paper-based reporting for
CDC-funded research. Currently, CDC's One Health Office has funded
surveillance and research at sites throughout the nation. This
surveillance form will be used to report all linked human and animal
testing for SARS-CoV-2 to CDC that is occurring through funded
surveillance activities, including the status and circumstances for
testing. This will relieve the requirement for less secure reporting
such as paper-based reporting forms sent through email.
More broadly, we expect this form may be generalized in the future
to encapsulate surveillance for other zoonotic respiratory viruses.
This surveillance form therefore offers the opportunity to test and
iterate upon surveillance mechanisms prior to the advancement of a
broader surveillance system.
One Health Case Investigation Form for Animals with SARS-CoV-2:
Currently, most animal samples that test positive for SARS-CoV-2 are
confirmed by USDA NVSL, and are reported to the World Organization for
Animal Health (OIE). However, the information collected is largely
restricted to
[[Page 9621]]
information on the animal case, including animal species, number of
affected animals, and clinical signs. Richer epidemiological data,
including the routes that animals become exposed to SARS-CoV-2 and
potential transmission events back to people, are needed to better
understand the zoonotic potential of SARS-CoV-2, whether transmission
is becoming sustained among animal populations, and the public health
risks that infected animals may pose. Through this data collection
tool, state and local public health and animal health officials will be
able to use a standardized approach to collect epidemiological data
while conducting One Health epidemiologic investigations over the
tool's expected reporting lifespan of three years.
CDC and USDA guidance recommends state-level health authorities,
namely state public health veterinarians and state animal health
officials, conduct follow-up investigations if and when an animal is
identified as positive for SARS-CoV-2. These officials, in addition to
other state, tribal, local, and territorial (STLT) collaborators
conducting research or surveillance within their jurisdiction are
therefore an appropriate target audience for this surveillance form.
This form involves voluntary reporting from STLT health officials
conducting epidemiological investigations to enter case information and
return it to CDC. This tool was designed by CDC staff at the request of
STLT partners.
These data will be used to describe the transmission dynamics and
natural history of SARS-CoV-2 infection. Specifically, this tool will
assist in collecting and compiling data to better understand the
zoonotic potential of SARS-CoV-2 from humans or other sources, and the
role animals infected with SARS-CoV-2 may play in onward transmission
to humans or other animals.
CDC requests approval for an estimated 9,000 annual burden hours
for this collection. There are no costs to respondents other than their
time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
State, tribal, local, and territorial One Health Case 50 20 1
health officials. Investigation Form for
Animals with SARS-CoV-2.
State, tribal, local, and territorial One Health Consultation 80 400 15/60
health officials. Form.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead,Information Collection Review Office,Office of Scientific
Integrity,Office of Science,Centers for Disease Control and Prevention.
[FR Doc. 2022-03708 Filed 2-18-22; 8:45 am]
BILLING CODE 4163-18-P
